Overexpression of CIP2A is associated with tumor aggressiveness, lymph node and lymphovascular involvement, and advanced stage colon cancer, which may partially explain why CIP2A functions as a prognostic marker in patients with wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy [10,36]. Here, KRAS is linked to malignant colon neoplasm.